A phase 1/2 study of autologous neuroblastoma tumor cells genetically modified to secrete il-2 in patients with high-risk neuroblastoma

Heidi V. Russell, Douglas Strother, Zhuyong Mei, Donna Rill, Edwina Popek, Ettore Biagi, Eric Yvon, Malcolm Brenner, Raphael Rousseau

Research output: Contribution to journal › Article › peer-review

36 Scopus citations

Fingerprint

Dive into the research topics of 'A phase 1/2 study of autologous neuroblastoma tumor cells genetically modified to secrete il-2 in patients with high-risk neuroblastoma'. Together they form a unique fingerprint.

Medicine & Life Sciences